<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00481312</url>
  </required_header>
  <id_info>
    <org_study_id>3005013</org_study_id>
    <nct_id>NCT00481312</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)</brief_title>
  <acronym>MIDEX</acronym>
  <official_title>A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Midazolam for Continuous Sedation of Ventilated Patients in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orion Corporation, Orion Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orion Corporation, Orion Pharma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients in ICU who need help with their breathing are put onto a machine called a ventilator
      and are also given a medicine, called a sedative, which helps them to sleep and makes them
      more comfortable. Midazolam is a sedative that is routinely used for these purposes.

      For most patients the aim of sedation is to make them sleepy but still able to respond to
      nursing staff (light sedation)

      Dexmedetomidine is a new sedative for use in intensive care and in this clinical study,
      dexmedetomidine is compared to midazolam. It is thought that dexmedetomidine might be
      slightly better at allowing patients to be sleepy but still respond to people around them. It
      also does not appear to affect patient's breathing. the purpose of this study is to test
      whether dexmedetomidine really does have these advantages compared to midazolam.

      in this study we hope to show that: dexmedetomidine is at least as good as midazolam in
      helping patients to sleep better and making them more comfortable, and that they are able to
      co-operate better with the staff treating them, and that patients treated with
      dexmedetomidine require a shorter time on the ventilator than those treated with midazolam.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase III, multi-centre, prospective, randomised, double-blind, double-dummy,
      active comparator study. The study consists of three periods: screening, double-dummy
      treatment and follow-up period.

      All patients admitted to ICU will be pre-screened according to inclusion and exclusion
      criteria prior to informed consent using available clinical data.

      Informed consent, screening and randomisation procedures should be completed within 72 hours
      from the time of admission to ICU and within 48 hours from starting continuous sedation.
      Eligible study subjects requiring light to moderate sedation (Richmond Agitation-Sedation
      Scale [RASS] = 0 to -3) will be randomised to either continue on midazolam or switch to
      dexmedetomidine. Patients should not have received any other continuously or regularly
      administered sedative agent than midazolam infusion during the last 12 hours except for
      opioid analgesics. Study treatments will be titrated to achieve an individually targeted
      sedation range determined on a daily basis. Rescue treatment (i.e. propofol boli) may be
      given if needed to achieve the target depth of sedation. Continued need for sedation will be
      assessed at a daily sedation stop, conducted at the same time each day. First sedation stop
      may be 12-36 hours from randomisation, depending on the time of day the study subject is
      randomised. The duration of study treatment is limited to a maximum of 14 days from
      randomisation. Following withdrawal of sedation, study subjects will be monitored for 48
      hours and contacted by telephone 31 and 45 days after randomisation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depth of sedation using the RASS. The target RASS range (target depth of sedation) should be 0 to -3 for a patient to be included in the study. The target may be amended during the study treatment, if clinically required</measure>
    <time_frame>RASS score will be assessed approximately 2 hourly during the treatment period and during the 48-hour follow-up period</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of mechanical ventilation the number of days the patient receives mechanical ventilation will be recorded</measure>
    <time_frame>This variable will be dependent on the individual patient and the number of days they require mechanical ventilation .</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nurse's assessment of subject communication with visual analogue scales (VAS)Patients rousability and ability to co-operate and communicate will be measured using a visual analogue scale.</measure>
    <time_frame>This will be measured at the end of every nursing shift whilst the patient remains on study treatment (maximum 14 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Number of days a patient is in ICU which will vary depending on the underlying illness of the patient</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">501</enrollment>
  <condition>Continuous Sedation in Initially Sedated Adults in ICU</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Midazolam</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Continuous Infusion</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Continuous Infusion</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years and over

          -  Clinical need for sedation of an initially intubated (or tracheotomised) and
             ventilated (with inspiratory assistance) patient

          -  Prescribed light to moderate sedation (target RASS = 0 to -3) using midazolam infusion

          -  Patients should be randomised within 72 hours from ICU admission and within 48 hours
             of commencing continuous sedation in the ICU

          -  Patients should have an expected requirement for sedation of at least 24 hours from
             time of randomisation

          -  Written informed consent must be obtained according to local regulations before
             starting any study procedures other than pre-screening.

        Exclusion Criteria:

          -  Acute severe intracranial or spinal neurological disorder due to vascular causes,
             infection, intracranial expansion or injury

          -  Uncompensated acute circulatory failure at time of randomisation (severe hypotension
             with MAP &lt; 55 mmHg despite volume and pressors)

          -  Severe bradycardia (HR &lt; 50 beats/min)

          -  AV-conduction block II-III (unless pacemaker installed)

          -  Severe hepatic impairment (bilirubin &gt; 101 µmol/L)

          -  Need for muscle relaxation at the time of randomisation (may only be used for
             intubation and initial stabilization)

          -  Loss of hearing or vision, or any other condition which would significantly interfere
             with the collection of study data

          -  Burn injuries requiring regular anaesthesia or surgery

          -  Use of centrally acting α2 agonists or antagonists at the time of randomisation,
             notably clonidine (see section 5.7 for prior and concomitant treatments)

          -  Known allergy to any of the study drugs or any excipients of the study drugs

          -  Patients who have or are expected to have treatment withdrawn or withheld due to poor
             prognosis

          -  Patients receiving sedation for therapeutic indications rather than to tolerate the
             ventilator (e.g. epilepsy)

          -  Patients unlikely to require continuous sedation during mechanical ventilation (e.g.
             Guillain-Barré syndrome)

          -  Patients who are unlikely to be weaned from mechanical ventilation; e.g.
             diseases/injuries primarily affecting the neuromuscular function of the respiratory
             apparatus such as clearly irreversible disease requiring prolonged ventilatory support
             (e.g. high spinal cord injury or advanced amyotrophic lateral sclerosis)

          -  Distal paraplegia

          -  Positive pregnancy test or currently lactating

          -  Received any investigational drug within the preceding 30 days

          -  Concurrent participation in any other interventional study (any study in which
             patients are allocated to different treatment groups and/or non-routine diagnostic or
             monitoring procedures are performed)

          -  Previous participation in this study

          -  Any other condition which, in the investigator's opinion, would make it detrimental
             for the subject to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Jakob, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Insel Spital, Bern CH-3010 Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Angela Ruck, BSc PhD</last_name>
    <role>Study Director</role>
    <affiliation>Orion Pharma R&amp;D Nottingham England</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ULB Erasme, Route de Lennik</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Brussel, Intensive Care Dept. Laarbeeklaan 101</name>
      <address>
        <city>Brussels</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaer Ziekenhuis Gent, Intensieve Zorgen, De Pintelaan 185</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Liege (Sart Tilman), Domaine de Sart-Tilman</name>
      <address>
        <city>Liege</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Tallinn Central Hospital, Ravi Stret 18</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Estonian Regional Hospital, Centre of Intensive Care, J. Sutiste Tee 18</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Estonian Regional Hospital, Dept. of Postoperative Intensive Care, J. Sutiste Tee 18</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tartu University Hospistal, Clinic of Anesthesiology and Intensive Care, L. Puusepa 8</name>
      <address>
        <city>Tartu</city>
        <zip>51014</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital, Kajaanintie 50</name>
      <address>
        <city>Oulu</city>
        <zip>90029 OYS</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital, ICU</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Angers, Reanimation medicale est de Mededicne Hyperbare, 4 Rue Larrey</name>
      <address>
        <city>Angers cedex 9</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Victor Dupouy Hopital Dupuytren, Service Reanimation Polyvalente, 69, Rue du Lt Colonel Prud'hon</name>
      <address>
        <city>Argenteuil</city>
        <zip>95107</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Grenoble, Service de Reanimation Medicale, Boulevard de la Chantourne, BP 217</name>
      <address>
        <city>Grenoble cedex 09</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier La Roche sur Yon CHD les Oudaireis, Service Reanimation CHD la Roche sur Yon, Les Oudairies</name>
      <address>
        <city>La Roche sur Yon Cedex</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Albert Calmette, Boulevard Du Pr. Jules Leclercq</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Limoges Hopital Dupuytren, Service de Reanimation Polyvalente, 2, Avenue Martin Luther King</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire d'Orleans, Reanimation Medicale, 1, rue Prote Madeleine, BP 2439</name>
      <address>
        <city>Orleans cedex 1</city>
        <zip>45032</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Bichat-Claude, Dept. D'Anasehesie et Reanimation Chirurgicale, 46, rue Henri-Huchard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Cochin Saint Vincent de Paul, Service de Reanimation Medicale, 27 Rue du Faubourg Saint Jacques</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Foch, Service Renimation, 40 Rue Worth, Suresnes Hauts de Seine</name>
      <address>
        <city>Paris</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Poitiers, Reanimation Medicale, 2, Rue de la Miletrie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Regional et Universitaire - Hopital Bretonneau Service Reanimation Medicale Polyvalente, 2, Boulevard Tonnelle, Tours cedex 9</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Bonn, Klinik u. Poliklinik f. Anasthesiologie u. Operative Intensivmedizin, Sigmund-Freud-Strasse 25</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Greifswald, Klinik u. Poliklinik f. Anasthesiologie u. Intensivmedizin, Friedrich-Loeffler-Str. 23b</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Tubingen, Klinik fur Anasthesiologie und Intensivmedizin, Hoppe-Seyler-Strasse 3</name>
      <address>
        <city>Tubingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU Medisch Centrum, De Boelelaan 1117</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gelre Hospitals - Locatie Lucas, A.Schweitzerlaan 32</name>
      <address>
        <city>Apeldoorn</city>
        <zip>7334 DZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Amphia Ziekenhuis, Dept. Intensieve Zorgen, Molengracht 21</name>
      <address>
        <city>Breda</city>
        <zip>4818</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Schweitzer Hospital, Locatie Dordwikj, Albert Schweitzerplaats 25</name>
      <address>
        <city>Dordrecht</city>
        <zip>3318 AT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kennemer Hospital, Boeerhaavelaan 29</name>
      <address>
        <city>Haarlem</city>
        <zip>2035 RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Elisabeth Ziekenhuis, Dept. Intensieve Zorgen, Hilvarenbeekseweg 60</name>
      <address>
        <city>Tilburg</city>
        <zip>5022 GC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Viecuri MC voor Noord-Limburg, Locatie Venlo, Dept. Intensieve Zorgen, Tegelseweg 210</name>
      <address>
        <city>Venlo</city>
        <zip>5912 BL</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken, Locatie Weezenlanden, Groot Wezenland 20</name>
      <address>
        <city>Zwolle</city>
        <zip>8011 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital, Intensive Care Unit, Jonas Liesvei 65</name>
      <address>
        <city>Bergen</city>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rikshospitalet, Universitetsklinikk, Sognsvannsveien 20</name>
      <address>
        <city>Oslo</city>
        <zip>0027</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ulleval University Hospital, Medical and Surgical ICU, Kirkeveien 166</name>
      <address>
        <city>Oslo</city>
        <zip>0450</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aker Universtetssykehus HF, Anestesiavdelingen, Trondheimsveien 235</name>
      <address>
        <city>Oslo</city>
        <zip>0514</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital, Freiburgstrasse 4</name>
      <address>
        <city>Bern</city>
        <zip>CH-3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Winterthur, Brauerstrasse 15,</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsspital Zurich, Klinik fur Innere Medizin, Intensivstation, Ramistrasse 100</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham, Department of Anaesthesia, Queen Elizabeth Hospital,</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Heartlands Hospital, Bordesely Green East</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital, Dept. of Intensive Care Level 4, Derriford Road</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Estonia</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2007</study_first_submitted>
  <study_first_submitted_qc>May 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2007</study_first_posted>
  <last_update_submitted>May 4, 2012</last_update_submitted>
  <last_update_submitted_qc>May 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Initial Sedation</keyword>
  <keyword>Mechanical ventilation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

